Home

David Pernock

CIK 1471956 · Pres & Chief Operating Officer · last filed 2021-02-04

David Pernock is a Pres & Chief Operating Officer who has filed 32 SEC Form 4 insider transactions across 2 companies since 2013. The most recent filing, for EGRX, was dated Feb 4, 2021. Across all open-market trades the lifetime net is +$294.4K, making them a net buyer over the disclosed history.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$0

Companies

2

Total Filings

32

Lifetime Open-Market Net

$294.4K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Pres & Chief Operating Officer 54,625 $2.14 $116.9K $76.9K 17 2021-02-04
Fibrocell Science, Inc. (FCSC) Delisted Chairman and CEO 105,600 — — $217.5K 11 2016-12-02

Recent Filings

32 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2021-02-04 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) +9,700 $0 EDGAR
2021-01-26 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Tax (F) −1,892 -$90.2K EDGAR
2021-01-11 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Tax (F) −906 -$46.2K EDGAR
2021-01-07 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Tax (F) −2,088 -$104.4K EDGAR
2020-01-27 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Tax (F) −1,793 -$104.0K EDGAR
2020-01-07 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed +20,596 -$51.9K EDGAR
2019-01-25 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Mixed +20,042 -$35.5K EDGAR
2018-01-09 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Grant (A) +10,000 $0 EDGAR
2017-05-19 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Buy (P) +255 $20.3K EDGAR
2017-05-16 EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted Buy (P) +200 $16.4K EDGAR
Showing 1–10 of 32
Page 1 of 4
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.